The SCN5A gene Brugada Syndrome Type 1 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the SCN5A gene, which are closely associated with Brugada Syndrome Type 1. This condition is a rare but serious heart rhythm disorder that can lead to sudden cardiac arrest, often in individuals without any underlying heart disease. The test is critical for individuals with a family history of Brugada Syndrome or unexplained sudden cardiac events, as it can help in the early detection and management of the condition.
The testing process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the SCN5A gene that may predispose an individual to Brugada Syndrome Type 1. The results of this test can provide valuable information for personalized treatment plans and preventive measures for affected individuals and their families.
The cost of the SCN5A gene Brugada Syndrome Type 1 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary to understand an individual's genetic risk for this potentially life-threatening condition. Given the complexity and importance of the test, individuals considering this testing should consult with a healthcare professional or genetic counselor to fully understand the implications of the test results for themselves and their family members.
The GPD1L gene plays a crucial role in the heart's electrical activity and its mutations are linked to Brugada Syndrome Type 2, a condition that affects the heart's rhythm. Individuals with this syndrome are at an increased risk of sudden cardiac death due to irregular heartbeats. The genetic test for Brugada Syndrome Type 2, focusing on the GPD1L gene, is a vital diagnostic tool for identifying individuals at risk. This test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED, an investment in health that could provide essential information for managing and monitoring the condition, potentially saving lives through early detection and preventive measures.
The "CACNA1C Gene Brugada Syndrome Type 3 Genetic Test" is a specific diagnostic tool used to identify mutations in the CACNA1C gene, which are associated with Brugada Syndrome Type 3. This condition is a rare inherited cardiac disorder that can lead to arrhythmias, fainting, and sudden cardiac death, particularly in young, healthy adults. The test is crucial for individuals with a family history of Brugada Syndrome or unexplained cardiac events, as it can help in making informed decisions regarding management and preventive measures for at-risk individuals.
Conducted at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the CACNA1C gene. This gene plays a vital role in the electrical activity of the heart, and mutations can disrupt normal heart rhythm, leading to the symptoms associated with Brugada Syndrome.
The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it provides into an individual's risk of developing Brugada Syndrome Type 3. By identifying genetic predispositions, patients and healthcare providers can work together to monitor heart health closely and implement preventive strategies to mitigate the risk of serious cardiac events.
The CACNB2 gene Brugada Syndrome Type 4 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CACNB2 gene, which are associated with Brugada Syndrome Type 4. Brugada Syndrome is a rare but serious condition that affects the heart's rhythm, potentially leading to sudden cardiac arrest in otherwise healthy individuals. The test is crucial for individuals with a family history of Brugada Syndrome or unexplained cardiac symptoms, as it can help in early detection and management of the condition.
At DNA Labs UAE, the test is offered at a cost of 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the CACNB2 gene. Results from this test can provide valuable information for risk assessment, allowing healthcare providers to recommend appropriate preventive measures or interventions to reduce the risk of cardiac events associated with Brugada Syndrome Type 4.
The SCN1B Gene Brugada Syndrome Type 5 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SCN1B gene, which are linked to Brugada Syndrome Type 5. This condition is a rare, inherited form of heart disease that can lead to dangerous heart rhythms and, in severe cases, sudden cardiac arrest. The test plays a crucial role in the early detection and management of this syndrome, enabling healthcare providers to implement preventive measures and tailor treatments for individuals at risk. Priced at 4400 AED, this genetic test is a valuable resource for individuals with a family history of Brugada Syndrome or unexplained cardiac symptoms, offering a pathway to better health outcomes through personalized medicine.
The KCNE3 Gene Brugada Syndrome Type 6 Genetic Test is a specialized diagnostic tool designed to identify mutations in the KCNE3 gene, which have been linked to Brugada Syndrome Type 6. Brugada Syndrome is a rare genetic disorder that affects the heart's rhythm, potentially leading to sudden cardiac arrest. The KCNE3 gene plays a crucial role in the function of heart cells, specifically in the regulation of potassium channels that are essential for the heart's electrical activity.
This test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED. By analyzing an individual's DNA, the test can determine whether they carry the genetic variations associated with Brugada Syndrome Type 6. This information is vital for assessing the risk of developing the condition and can guide decisions regarding monitoring, lifestyle adjustments, and preventive measures to mitigate the risk of heart complications. It is especially recommended for individuals with a family history of Brugada Syndrome or unexplained cardiac events.
The SCN3B Gene Brugada Syndrome Type 7 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SCN3B gene that are associated with Brugada Syndrome Type 7. Brugada Syndrome is a potentially life-threatening heart condition that can cause dangerous irregular heart rhythms. These arrhythmias can lead to sudden cardiac arrest in otherwise healthy individuals, often without warning.
The test targets the SCN3B gene, which plays a crucial role in the proper function of heart cells. Mutations in this gene can disrupt the normal electrical activity of the heart, leading to the characteristic patterns observed in Brugada Syndrome. By detecting these specific genetic variations, the test can help in diagnosing individuals at risk of this condition, allowing for appropriate management strategies to be implemented.
Offered at a cost of 4400 AED, the SCN3B Gene Brugada Syndrome Type 7 Genetic Test at DNA Labs UAE represents a critical step forward in the early detection and prevention of sudden cardiac death associated with Brugada Syndrome. This test is particularly important for individuals with a family history of the condition or those who have experienced unexplained syncope or cardiac arrest, as it can provide vital information for risk assessment and treatment planning.
The HCN4 Gene Brugada Syndrome Type 8 Genetic Test is a specialized diagnostic tool used to identify mutations in the HCN4 gene, which have been linked to Brugada Syndrome Type 8. This condition is a rare genetic disorder that affects the heart's rhythm, potentially leading to sudden cardiac arrest in otherwise healthy individuals. The test is crucial for individuals with a family history of Brugada Syndrome or unexplained symptoms related to heart rhythm anomalies, as it can provide essential information for managing the condition and preventing serious complications.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA to detect specific mutations in the HCN4 gene. The process is highly accurate and can offer peace of mind or necessary medical intervention to those at risk.
The cost of the HCN4 Gene Brugada Syndrome Type 8 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify the genetic variations associated with the condition. For patients and families affected by Brugada Syndrome, this test represents a critical step towards understanding their genetic risk and making informed decisions about their health care and lifestyle.
The SLMAP gene Brugada Syndrome Type 9 genetic test is a specialized diagnostic examination designed to identify mutations in the SLMAP gene, which are associated with Brugada Syndrome Type 9. This condition is a rare genetic disorder that affects the heart's rhythm, potentially leading to sudden cardiac arrest in otherwise healthy individuals. The test is a critical tool for individuals with a family history of Brugada Syndrome or unexplained cardiac symptoms, as it aids in the early detection and management of this condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genetic sequencing technologies to accurately identify the presence of specific mutations in the SLMAP gene. The results of this test can provide essential information for personalized treatment plans, including lifestyle adjustments, medication, or even the installation of an implantable cardioverter-defibrillator (ICD) to prevent sudden death from cardiac arrhythmias.
The cost of the SLMAP gene Brugada Syndrome Type 9 genetic test at DNA Labs UAE is 4400 AED. Given the complexity of the test and the specialized technology required, this price reflects the comprehensive nature of the analysis and the invaluable insight it offers into managing Brugada Syndrome effectively. For individuals at risk, this test represents a critical step towards ensuring heart health and preventing potential fatal cardiac events.
The CNOT3 gene is essential in the regulation of gene expression and plays a critical role in various biological processes, including heart development. Mutations or dysfunctions in the CNOT3 gene can lead to cardiac defects, which can manifest as congenital heart diseases. These conditions are serious and can affect an individual's health and quality of life from birth.
Recognizing the importance of early detection and intervention, DNA Labs UAE offers a specialized genetic test specifically designed to identify mutations in the CNOT3 gene that are associated with cardiac defects. This test is a crucial tool for individuals with a family history of heart conditions or for those who have children with unexplained cardiac anomalies. Early detection through this test can facilitate timely medical interventions, potentially improving outcomes and quality of life for those affected.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic alterations in the CNOT3 gene. The process is meticulous, ensuring high accuracy and reliability of the results.
The cost of the CNOT3 related genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated, especially for families at risk of congenital heart diseases. Knowing one's genetic predisposition allows for informed decision-making regarding health and family planning. Moreover, it opens the door to personalized medicine, where treatments and monitoring can be tailored to the individual's genetic makeup, offering the best possible outcomes.
